Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
HuR (human)
p Phosphorylation
ac Acetylation
me Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
ub Ubiquitination
sm Sumoylation
ne Neddylation
gl O-GlcNAc
ga O-GalNAc
pa Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage
sc Succinylation

Overview
HuR Involved in 3'-UTR ARE-mediated MYC stabilization. Binds avidly to the AU-rich element in FOS and IL3/interleukin-3 mRNAs. In the case of the FOS AU-rich element, HUR binds to a core element of 27 nucleotides that contain AUUUA, AUUUUA and AUUUUUA motifs. Binds preferentially to the 5'-UUUU[AG]UUU-3' motif in vitro. Identified in a mRNP complex, at least composed of DHX9, DDX3X, ELAVL1, HNRNPU, IGF2BP1, ILF3, PABPC1, PCBP2, PTBP2, STAU1, STAU2, SYNCRIP and YBX1. Interacts with ANP32A, EIF2C1 and EIF2C2. Ubiquitous. Belongs to the RRM elav family. Note: This description may include information from UniProtKB.
Protein type: RNA binding protein
Chromosomal Location of Human Ortholog: 19p13.2
Cellular Component: nucleoplasm; membrane; cytoplasm; nucleus; cytosol
Molecular Function: mRNA binding; protein binding; mRNA 3'-UTR binding; RNA binding; double-stranded RNA binding; nucleotide binding; AU-rich element binding; protein kinase binding
Biological Process: positive regulation of translation; RNA metabolic process; mRNA stabilization; multicellular organismal development; gene expression; mRNA metabolic process
Reference #:  Q15717 (UniProtKB)
Alt. Names/Synonyms: ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R); ELAV-like protein 1; ELAV1; ELAVL1; embryonic lethal, abnormal vision, drosophila, homolog-like 1; Hu antigen R; Hu-antigen R; Hua; HUR; MelG
Gene Symbols: ELAVL1
Molecular weight: 36,092 Da
Basal Isoelectric point: 9.23  Predict pI for various phosphorylation states
CST Pathways:  AMPK Signaling
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology® Total Proteins
Select Structure to View Below

HuR

Protein Structure Not Found.


STRING  |  Wikipedia  |  Reactome  |  neXtProt  |  Protein Atlas  |  BioGPS  |  Scansite  |  Pfam  |  RCSB PDB  |  Phospho3D  |  Phospho.ELM  |  NetworKIN  |  Source  |  UCSD-Nature  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Sites Implicated In
carcinogenesis, altered: S318‑p
cell cycle regulation: S242‑p, S318‑p
cell growth, altered: S242‑p
cell motility, altered: S221‑p, S318‑p
RNA stability, altered: S88‑p, S100‑p, T118‑p, S158‑p, S221‑p
translation, altered: S158‑p, S221‑p
intracellular localization: T118‑p, S158‑p, Y200‑p, S221‑p, S242‑p, S318‑p
molecular association, regulation: T118‑p, S158‑p, S221‑p, S242‑p, S318‑p
phosphorylation: S158‑p, S221‑p

Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 3 S2-p ______MsNGyEDHM
0 1 Y5-p ___MsNGyEDHMAED
0 4 Y26-p RTNLIVNyLPQNMtQ
0 2 T32-p NyLPQNMtQDELRsL
0 1 S38-p MtQDELRsLFsSIGE
0 1 S41-p DELRsLFsSIGEVEs
0 1 S48-p sSIGEVEsAkLIRDk
0 14 K50-ub IGEVEsAkLIRDkVA
0 8 K55-ub sAkLIRDkVAGHSLG
1 3 Y63-p VAGHSLGyGFVNyVT
1 1 Y68-p LGyGFVNyVTAkDAE
0 14 K72-ub FVNyVTAkDAERAIN
0 1 K72-sc FVNyVTAkDAERAIN
0 1 N79 kDAERAINtLNGLRL
0 2 T80-p DAERAINtLNGLRLQ
3 0 S88-p LNGLRLQsKTIkVSY
0 2 K92-ub RLQsKTIkVSYARPS
3 2 S100-p VSYARPSsEVIkDAN
0 2 K104-ub RPSsEVIkDANLyIs
0 5 Y109-p VIkDANLyIsGLPRT
0 1 S111-p kDANLyIsGLPRTMt
6 3 T118-p sGLPRTMtQkDVEDM
0 4 K120-ub LPRTMtQkDVEDMFS
0 1 T143-p RVLVDQTtGLsRGVA
0 1 S146-p VDQTtGLsRGVAFIR
3 0 S158-p FIRFDKRsEAEEAIT
1 0 K182-ub SSEPITVkFAANPNQ
0 20 K191-ub AANPNQNkNVALLsQ
0 10 S197-p NkNVALLsQLyHsPA
1 233 Y200-p VALLsQLyHsPArrF
5 91 S202-p LLsQLyHsPArrFGG
0 1 R205-m1 QLyHsPArrFGGPVH
0 10 R206-m1 LyHsPArrFGGPVHH
0 1 R206 LyHsPArRFGGPVHH
1 0 R217-me PVHHQAQrFrFsPMG
0 16 R217-m1 PVHHQAQrFrFsPMG
0 6 R217-m2 PVHHQAQrFrFsPMG
0 3 R219-m1 HHQAQrFrFsPMGVD
0 1 R219-m2 HHQAQrFrFsPMGVD
8 0 S221-p QAQrFrFsPMGVDHM
1 0 S242-p NVPGNASsGWCIFIY
0 4 K283-ub IRDFNTNkCKGFGFV
1 0 S304-p EAAMAIAsLNGYRLG
1 9 K313-ub NGYRLGDkILQVsFk
7 1 S318-p GDkILQVsFkTNkSH
0 1 K320-ac kILQVsFkTNkSHk_
0 39 K320-ub kILQVsFkTNkSHk_
0 2 K323-ub QVsFkTNkSHk____
1 0 K326-ub FkTNkSHk_______
  mouse

 
S2 ______MSNGYEDHM
Y5 ___MSNGYEDHMAED
Y26 RTNLIVNYLPQNMTQ
T32 NYLPQNMTQEELRSL
S38 MTQEELRSLFSSIGE
S41 EELRSLFSSIGEVES
S48 SSIGEVESAkLIRDk
K50-ub IGEVESAkLIRDkVA
K55-ub SAkLIRDkVAGHSLG
Y63 VAGHSLGYGFVNYVT
Y68 LGYGFVNYVTAkDAE
K72-ub FVNYVTAkDAERAIs
K72 FVNYVTAKDAERAIs
S79-p kDAERAIstLNGLRL
T80-p DAERAIstLNGLRLQ
S88 LNGLRLQSKTIkVSY
K92-ub RLQSKTIkVSYARPS
S100 VSYARPSSEVIkDAN
K104-ub RPSSEVIkDANLYIS
Y109 VIkDANLYISGLPRT
S111 kDANLYISGLPRTMT
T118 SGLPRTMTQkDVEDM
K120-ub LPRTMTQkDVEDMFS
T143 RVLVDQTTGLSRGVA
S146 VDQTTGLSRGVAFIR
S158 FIRFDKRSEAEEAIT
K182 SSEPITVKFAANPNQ
K191-ub AANPNQNkNMALLSQ
S197 NkNMALLSQLyHsPA
Y200-p MALLSQLyHsPARrF
S202-p LLSQLyHsPARrFGG
R205 QLyHsPARrFGGPVH
R206-m1 LyHsPARrFGGPVHH
R206-m2 LyHsPARrFGGPVHH
R217 PVHHQAQRFrFSPMG
R217-m1 PVHHQAQrFrFSPMG
R217-m2 PVHHQAQrFrFSPMG
R219-m1 HHQAQrFrFSPMGVD
R219 HHQAQrFRFSPMGVD
S221 QAQrFrFSPMGVDHM
S242 NVPGNASSGWCIFIY
K283-ub IRDFNTNkCKGFGFV
S304 EAAMAIASLNGYRLG
K313 NGYRLGDKILQVsFk
S318-p GDKILQVsFkTNkSH
K320 KILQVsFKTNkSHK_
K320-ub KILQVsFkTNkSHK_
K323-ub QVsFkTNkSHK____
K326 FkTNkSHK_______
  rat

 
S2 ______MSNGYEDHM
Y5 ___MSNGYEDHMAED
Y26 RTNLIVNYLPQNMTQ
T32 NYLPQNMTQEELRSL
S38 MTQEELRSLFSSIGE
S41 EELRSLFSSIGEVES
S48 SSIGEVESAKLIRDK
K50 IGEVESAKLIRDKVA
K55 SAKLIRDKVAGHSLG
Y63 VAGHSLGYGFVNYVT
Y68 LGYGFVNYVTAKDAE
K72 FVNYVTAKDAERAIS
K72 FVNYVTAKDAERAIS
S79 KDAERAISTLNGLRL
T80 DAERAISTLNGLRLQ
S88 LNGLRLQSKTIKVSY
K92 RLQSKTIKVSYARPS
S100 VSYARPSSEVIKDAN
K104 RPSSEVIKDANLYIS
Y109 VIKDANLYISGLPRT
S111 KDANLYISGLPRTMT
T118 SGLPRTMTQKDVEDM
K120 LPRTMTQKDVEDMFS
T143 RVLVDQTTGLSRGVA
S146 VDQTTGLSRGVAFIR
S158 FIRFDKRSEAEEAIT
K182 SSEPITVKFAANPNQ
K191 AANPNQNKNMALLSQ
S197 NKNMALLSQLYHsPA
Y200 MALLSQLYHsPARrF
S202-p LLSQLYHsPARrFGG
R205 QLYHsPARrFGGPVH
R206-m1 LYHsPARrFGGPVHH
R206 LYHsPARRFGGPVHH
R217 PVHHQAQRFRFSPMG
R217-m1 PVHHQAQrFRFSPMG
R217 PVHHQAQRFRFSPMG
R219 HHQAQrFRFSPMGVD
R219 HHQAQrFRFSPMGVD
S221 QAQrFRFSPMGVDHM
S242 NVPGNASSGWCIFIY
K283 IRDFNTNKCKGFGFV
S304 EAAMAIASLNGYRLG
K313 NGYRLGDKILQVSFK
S318 GDKILQVSFKTNKSH
K320 KILQVSFKTNKSHK_
K320 KILQVSFKTNKSHK_
K323 QVSFKTNKSHK____
K326 FKTNKSHK_______
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.